AACR 2015 Videos Featuring the LiquidBiopsy System & Workflow

André de Fusco and Dr. Paul Dempsey (CEO and CSO of Cynvenio Biosystems Inc.) share their perspective on the need to simultaneously isolate cfDNA and circulating tumor cells (CTCs) from the same sample.

 

From the AACR 2015 exhibit floor, Vidya Venkatesh of Thermo Fisher Scientific shares the advantages of LiquidBiopsy system and workflow. From collection and stabilization to excellent recovery and downstream analysis this system isolates both cell-free DNA (cfDNA) and circulating tumor cells (CTCs) from a single whole-blood sample.